Ítem
Solo Metadatos

Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema The Pan-American Collaborative Retina Study Group Results

Mostrar el registro sencillo de la publicación
dc.creatorArevalo, J. Fernandospa
dc.creatorMaia, Mauriciospa
dc.creatorGarcia-Amaris, Rafael A.spa
dc.creatorRoca, Jose A.spa
dc.creatorSanchez, Juan G.spa
dc.creatorBerrocal, Maria H.spa
dc.creatorWu, Lihtehspa
dc.date.accessioned2020-08-06T16:20:47Z
dc.date.available2020-08-06T16:20:47Z
dc.date.created2009-06-22spa
dc.description.abstractObjective: To determine the feasibility, safety, and clinical effect of intravitreal (IVT) bevacizumab (Avastin; Genentech, Inc., San Francisco, CA) in patients with refractory cystoid macular edema (CME) after cataract surgery. Design: Interventional, retrospective, multicenter study.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1016/j.ophtha.2009.04.006
dc.identifier.issnISSN: 1549-4713
dc.identifier.issnEISSN: 0161-6420
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/26147
dc.language.isoengspa
dc.publisherElsevierspa
dc.relation.citationEndPage1487
dc.relation.citationIssueNo. 8
dc.relation.citationStartPage1481
dc.relation.citationTitleOphthalmology
dc.relation.citationVolumeVol. 116
dc.relation.ispartofOphthalmology, ISSN: 1096-1208 ; EISSN: 0882-4010, Vol.116, No.8 (August, 2009); pp.1481-1487spa
dc.relation.urihttps://www.aaojournal.org/article/S0161-6420(09)00358-3/fulltextspa
dc.rights.accesRightsinfo:eu-repo/semantics/restrictedAccess
dc.rights.accesoRestringido (Acceso a grupos específicos)spa
dc.sourceOphthalmologyspa
dc.source.instnameinstname:Universidad del Rosario
dc.source.reponamereponame:Repositorio Institucional EdocUR
dc.subject.keywordAgedspa
dc.subject.keywordAgedspa
dc.subject.keyword80 and overspa
dc.subject.keywordAngiogenesis Inhibitorsspa
dc.subject.keywordAntibodiesspa
dc.subject.keywordMonoclonalspa
dc.subject.keywordAntibodiesspa
dc.subject.keywordMonoclonalspa
dc.subject.keywordHumanizedspa
dc.subject.keywordBevacizumabspa
dc.subject.keywordCataract Extractionspa
dc.subject.keywordFeasibility Studiesspa
dc.subject.keywordFemalespa
dc.subject.keywordFluorescein Angiographyspa
dc.subject.keywordFollow-Up Studiesspa
dc.subject.keywordHumansspa
dc.subject.keywordInjectionsspa
dc.subject.keywordMacular Edemaspa
dc.subject.keywordMalespa
dc.subject.keywordPostoperative Complicationsspa
dc.subject.keywordPseudophakiaspa
dc.subject.keywordRetrospective Studiesspa
dc.subject.keywordTomographyspa
dc.subject.keywordOptical Coherencespa
dc.subject.keywordTreatment Outcomespa
dc.subject.keywordVascular Endothelial Growth Factor Aspa
dc.subject.keywordVisual Acuityspa
dc.subject.keywordVitreous Bodyspa
dc.titleIntravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema The Pan-American Collaborative Retina Study Group Resultsspa
dc.title.TranslatedTitleBevacizumab intravítreo para el edema macular cistoide pseudofáquico refractario Resultados del grupo de estudio de la retina colaborativa panamericanaspa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Colecciones
Artículos